Articles On Avita Medical (ASX:AVH)

The Avita Medical Inc (ASX: AVH) share price has lost more than 60% over one year, despite the company showing growth and delivering record revenues in FY20. Is the Avita share price a good buy at this level, and what of its prospects for...

Last year was an extraordinary year. There were some big performances in the ASX 200 (ASX: XJO), but there were also some bad ones. This article is about the three worst performers, and how it happened. COVID-19 completely smashed some indu...

The S&P/ASX 200 Index (ASX: XJO) has returned from the Christmas break in style and is storming higher. In late morning trade the benchmark index is up 0.65% to 6,708.7 points. Four shares that have failed to follow the market higher t...

On the ASX this week, much is being made of S&P Global Inc’s quarterly index rebalancing that takes place today. Indexes work by constantly updating their inclusions and weightings to reflect the status of the broader market of the tim...

The market may be dropping lower on Monday, but that hasn’t stopped the Kogan.com Ltd (ASX: KGN) share price from charging higher. At one stage today, the ecommerce company’s shares were up as much as 7.5% to $19.40. The Kogan share price...

Every Monday I like to look at ASIC’s short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels can sometimes...

On 14th December 2020, ASX 200 ended in green as there was a rise of 0.26% to 6660.20. On the same day, industrials sector rose by 1.40% and financials sector increased by 1.02%. Sector Summary (Source: Refinitiv (Thomson Reuters)) Move...

Summary The prominent ASX indices have been rebalanced, effective from 21 December 2020. After the demerger of Iluka Resources from Deterra Royalties, both have been retained in the ASX 200. Afterpay has become one of the 20 most prom...

A number of shares could be on the move on Monday after S&P Dow Jones Indices announced its quarterly rebalance of the S&P/ASX Indices. This will see a number of popular shares added and dumped out of our major indices. Here is a s...

On Friday the S&P/ASX 200 Index (ASX: XJO) finished a positive week on a disappointing note. The benchmark index fell 0.6% to 6,642.6 points. Will the market be able to bounce back from this on Monday? Here are five things to watch: AS...

The Immutep Ltd (ASX: IMM) share price is on fire today, rising close to 60%. Immutep shares closed at 28 cents a share yesterday afternoon but opened at 45 cents this morning before rising to a high of 54 cents. The Immutep share price ha...

Every Monday I like to look at ASIC’s short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels can sometimes...

Earlier this week I looked at a couple of healthcare shares that have been tipped as potential market-beaters. Today, I thought I would take a look at the healthcare sector again, but this time at the small end of town. Two small cap healt...

In morning trade the Avita Therapeutics Inc (ASX: AVH) share price is pushing higher after the release of its first quarter update. At the time of writing the regenerative medicine company’s shares are up 2% to $6.23. How did Avita perform...

Regenerative medicine company AVITA Therapeutics (ASX:AVH) has announced a preclinical research collaboration pairing its Spray-On Skin Cells with Houston Methodist Research Institute’s expertise in reversing cellular aging.

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a very strong gain. At the time of writing the benchmark index is up 1.7% to 6,297.4 points. Four shares that have climbed more than most today are...

Are you looking for some small cap ASX shares to add to your watchlist? Then I would highly recommend you take a look at the ones listed below. Here’s why I think they have a lot of potential and are worth keeping a close eye on: Avita Me...

The S&P/ASX 200 Index (ASX: XJO) dropped by around 2% today, falling by 1.7% to 6,051 points. Here are some of the highlights from the ASX today: Widespread selling Overnight there was a selloff in international markets, seemingly on w...

ASX shares have a long track record of innovation, and of punching above their weight. For example, Avita Therapeutics Inc (ASX: AVH) is pioneering spray on skin for treating burns. However, Afterpay Ltd (ASX: APT), with no technological a...

The Avita Therapeutics Inc (ASX: AVH) share price has started the week in a positive fashion. The regenerative medicine company’s shares are up over 3% to $7.43 in afternoon trade. Why is the Avita share price charging higher? The catalyst...

After 30 years of investing I have made my fair share of mistakes, but I have also had some great investments. A good ASX share in my view can be 1 of 2 things. A solid value investment, where I have been able to find an undervalued good c...

Shares in Avita Thereapeutics Inc (ASX: AVH) surged nearly 15% higher following the company’s release of its annual report for FY20. The Avita share price soared to $7.10 at the opening bell before being sold down to a more modest gain of...

ShareCafeOvernight: Fly Me To The Moon World Overnight SPI Overnight (Sep) 6095.00 + 15.00 0.25% S&P ASX 200 6116.40 – 45.00 – 0.73% S&P500 3478.73 + 35.11 1.02% Nasdaq Comp 11665.06 + 198.59 1.73% DJIA 28331.92 + 83.48...

World Overnight SPI Overnight (Sep) 6095.00 + 15.00 0.25% S&P ASX 200 6116.40 – 45.00 – 0.73% S&P500 3478.73 + 35.11 1.02% Nasdaq Comp 11665.06 + 198.59 1.73% DJIA 28331.92 + 83.48 0.30% S&P500 VIX 23.27 + 1.24 5.6...

The ASX200 rose 0.5% in July led by materials, technology and consumer staples; the August reporting season may find companies hesitant to provide guidance amid an uncertain outlook -The ASX200 tottered to a monthly gain of 0.5% in July-The...

Like all financial markets, ASX shares produce winners and losers. Some companies soar to spectacular market capitalisations as their product or service takes off. Others see share prices deteriorate as markets and demand shift. When inv...

It seems investors in these two ASX medical shares have taken the opportunity to lock in recent gains, sending prices down significantly in July. The Avita Therapeutics Inc (ASX: AVH) share price fell more than 30% in July as sales faltere...

In July, the S&P/ASX 200 (ASX: XJO) saw a halt to previous gains. Rising coronavirus infections in Victoria tempered investor appetite with the index ending the month 29.9 points down. On that note, let’s take a look at the worst perfo...

Despite a disappointing finish to the month, the S&P/ASX 200 Index (ASX: XJO) recorded a 0.5% gain to end it at 5927.8 points. Unfortunately, not all shares on the index were climbing higher with the market in July. Here’s why these we...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

The medical device industry includes any device which can diagnose, prevent, or treat a disease or other condition. Examples range from bandages and syringes to pacemakers and prostheses. These technologies save and improve lives by detect...

The Avita Therapeutics Inc (ASX: AVH) (NASDAQ: RCEL) share price was trading 10.53% lower today following an investor update to do with its BARDA partnership. For context, the broader Australian share market or S&P/ASX 200 (ASX: XJO) wa...

The S&P/ASX 200 Index (ASX: XJO) fell by 0.6% today to 5,919 points. The alarming COVID-19 spread continues in Melbourne with Victoria reporting 288 new cases today. However, two new infections in NSW that seemingly came from a Sydney...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to end the week in the red. At the time of writing the benchmark index is down 0.25% to 5,940.4 points. Four shares that have fallen more than most today are listed be...

The Avita (ASX: AVH) share price is down more than 1% after providing an update for FY20. What is Avita? Avita is a regenerative medicine company. It aims to address unmet medical needs in burns, chronic wounds and aesthetics indications. I...

The AVITA Therapeutics Inc (ASX: AVH) share price will be on watch on Friday after the release of its fourth quarter update. How did AVITA perform in the fourth quarter? For the fourth quarter of FY 2020, the regenerative medicine company...

Australia is an amazingly innovative country – from the medical application of penicillin, the invention of WiFi, right through to the cochlear implant or bionic ear. Heck, Australia was even the birthing ground for what would become Googl...

In early afternoon trade the S&P/ASX 200 Index (ASX: XJO) looks set to start the new financial year on a positive note. At the time of writing the benchmark index is up 0.9% to 5,949.1 points. Four shares that have failed to follow the...

After redomiciling to the United States yesterday, the Avita Therapeutics Inc (ASX: AVH) share price is up 8.4% today. Avita Medical’s ordinary shares were transferred to Avita Therapeutics, based out of the US state of Delaware, via a sc...

The S&P/ASX 200 Index (ASX: XJO) rose by 0.1% to 5,943 points today. It was retail that dominated the headlines. According to the stats produced by the Australian Bureau of Statistics (ABS), Australian retail sales surged 16.3% in May...

Allied health group Advent Health is preparing to join the ranks of the ASX by way of a reverse takeover next month with a plan to improve efficiencies and boost profitability of its founding practices. The move entails shell company Mill...

The journey of each individual medical treatment from idea to market requires the involvement of multiple parties big and small. The general consensus seems to be that it takes a big player to get a drug to market, which more often than not...

The bulls are back following a massive almost 40 per cent upwards run over the last 50 days, but bearish investors are holding on to a range of theories as to why the worst is yet to come. Since the March 23 low, stocks have run harder than...

In the past fortnight there were over 30 directors trades of $100,000 or more among ASX small cap directors. The list included multiple groups of directors. Five directors from water treatment stock Phoslock (ASX:PET) put in $1.3m between t...

Morningstar believes there are some real bargain stocks to be found on the ASX. It has just released its monthly ‘Best Stock Ideas’ report highlighting companies trading at discounts to its assessed fair values. Three of them were small cap...

Due to the favourable tailwinds that it is experiencing, I believe the healthcare sector is a great place to invest with a long term view. But with so many options for investors to choose from, which ones should you be buying? Below are th...

02 Jun 2020 - AVITA Medical (ASX:AVH) has submitted an Investigational Device Exemption (IDE) supplement with the US Food and Drug Administration (FDA) for a clinical trial to inve…

Around 12 months ago, we noted that Avita Medical (AVH) – which provides a novel approach to skin regeneration – was a business worth keeping tabs on.  Although its share price has felt the effects of the COVID-19 market sell-off, our posit...

Last year was a solid year for many ASX stocks and 2020 was also looking pretty good until COVID-19 struck the markets in late February. Earlier this week Reuben Adams recapped which of last year’s top mining and exploration companies have...

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...